The Patent Finder

Methods for the Acylation of Maytansinol

ImmunoGen, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/705,731, filed Sep 26, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,012,629Methods for the Acylation of Maytansinol
In force
 · High confidence
UsedRemaining
ImmunoGen, Inc.In forceHigh confidence
US 9,469,655Methods for the Acylation of Maytansinol
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 9,796,731Methods for the Acylation of Maytansinol
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 10,100,062Methods for the Acylation of Maytansinol
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 10,461,449Methods for the Acylation of Maytansinol
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 10,944,190Methods for the Acylation of Maytansinol
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
Application 17/732,953Methods for the Acylation of Maytansinol
Abandoned
Abandoned Oct 7, 2022
ImmunoGen, Inc.AbandonedAbandoned Oct 7, 2022
Application 17/938,119Methods for the Acylation of Maytansinol
Abandoned
Abandoned Jun 21, 2023
ImmunoGen, Inc.AbandonedAbandoned Jun 21, 2023
Application 18/130,707Methods for the Acylation of Maytansinol
Abandoned
Abandoned Dec 8, 2023
ImmunoGen, Inc.AbandonedAbandoned Dec 8, 2023
Application 18/242,321Methods for the Acylation of Maytansinol
Abandoned
Abandoned Jan 22, 2024
ImmunoGen, Inc.AbandonedAbandoned Jan 22, 2024
2 more records in this group · Pro
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
Upgrade to Pro
6 of these are in force and held by ImmunoGen, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited